Our results suggest that etiological factor VEGF-A needs to be augmented alongwith regulation of inflammation, as noted here by consistently increased CCL2, either by hematopoietic cell transplantation or by defining other neurotrophic and proinflammatory factors involved in ALS. The gene discussed is VEGFA; the disease is amyotrophic lateral sclerosis.